Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' Disease

Endocrine Journal

Volumn 52, Issue 5, 2005, Pages 505-510

  Shibayama, Keiko ^a   Ohyama, Yoshihide ^a   Yokota, Yukifumi ^a   Ohtsu, Shigeyuki ^a   Takubo, Noriyuki ^a   Matsuura, Nobuo ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Child; Graves' disease; Thyroid stimulating antibodies (TSAb); Thyrotropin receptor autoantibodies (TRAB); Thyrotropin binding inhibitory immunoglobulins (TBII)

Indexed keywords

ANTITHYROID AGENT; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN BINDING INHIBITORY IMMUNOGLOBULIN; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENDOCRINE OPHTHALMOPATHY; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; METABOLISM; RELAPSE; REMISSION; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ANTITHYROID AGENTS; AUTOANTIBODIES; CHILD; FEMALE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; RECEPTORS, THYROTROPIN; RECURRENCE; REMISSION INDUCTION; SENSITIVITY AND SPECIFICITY;

EID: 27744503280     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.52.505     Document Type: Article

References (33)

1. Akamizu T (2001) Antithyrotropin receptor antibody: An update. Thyroid 11: 1123-1134.
2. Weetman AP, McGregor AM (1994) Autoimmmune thyroid disease: Further developments in our understanding. Endocr Rev 15: 788-830.
3. Gupta MK (1992) Thyrotropin receptor antibodies: Advances and importance of detection techniques in thyroid diseases. Clin Biochem 25: 193-199.
4. Orgiazzi J (2000) Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 29: 339-355.
5. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM (1998) The thyrotropin (TSH) receptor: Interaction with TSH and autoantibodies. Endocr Rev 19: 673-716.
6. Yokoyama N, Izumi M, Katamine S, Nagataki S (1987) Heterogeneity of Graves' immunoglobulin G: Comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection. J Clin Endocrinol Metab 64: 215-218.
7. Watanabe Y, Tahara K, Hirai A, Tada H, Kohn LD, Amino N (1997) Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor. Thyroid 7: 13-19.
8. Bliddal H, Bech K, Siersbæk-Nielsen K, Friis T (1983) The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment. J Endocrinol Invest 6: 259-262.
9. Foley TP Jr (1998) Mediators of thyroid diseases in children. J Pediatr 132: 569-570.
10. Brown RS, Kertiles LP, Rosenfield C, Kleimann RE, Crigler JF Jr (1986) Thyrotropin-receptor autoantibodies in children and young adults with Graves' disease. Am J Dis Child 140: 238-241.
11. Foley TP Jr, White C, New A (1987) Juvenile Graves disease: Usefulness and limitations of thyrotropin receptor antibody determinations. J Pediatr 110: 378-386.
12. Harada S (1991) Studies on TSH receptor antibodies (TRAb) in patients with juvenile Graves' disease - Clinical studies on usefulness of TRAb determinations - . J Jpn Pediatr Soc 95: 1751-1757 (In Japanese).
13. Botero D, Brown RS (1998) Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: Clinical utility in children and adolescents with Graves disease. J Pediatr 132: 612-618.
14. Davies TF, Roti E, Braverman LE, DeGroot LJ (1998) Thyroid controversy - Stimulating antibodies. J Clin Endocrinol Metab 83: 3777-3785.
15. Saravanan P, Dayan CM (2001) Thyroid autoantibodies. Endocrinol Metab Clin North Am 30: 315-337.
16. Inui T, Kouki T, Yamashiro K, Hachiya T, Ochi Y, Kajita Y, Sato Y, Nagata A (1998) Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay. Thyroid 8: 319-325.
17. Kamijo K, Nagata A, Sato Y (1999) Clinical significance of a sensitive assay for thyroid-stimulating antibodies in Graves' disease using polyethylene glycol at high concentrations and porcine thyroid cells. Endocr J 46: 397-403.
18. Tamaki H, Amino N, Miyai K (1988) On standardization of the radioreceptor assay for antithyrotropin receptor antibody. Clin Chem 34: 1662.
19. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577.
20. Campbell G (1994) Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Stat Med 13: 499-508.
21. Ilicki A, Gamstedt A, Karlsson FA (1992) Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies. J Clin Endocrinol Metab 74: 1090-1094.
22. Kawai K, Tamai H, Matsubayashi S, Mukuta T, Morita T, Kubo C, Kuma K (1995) A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs. Clin Endocrinol (Oxf) 43: 551-556.
23. Matsuura N, Konishi J, Yuri K, Harada S, Fujieda K, Nohara Y, Mikami Y, Kasagi K, Iida Y, Hosoda A, Okuno A (1990) Comparison of atrophic and goitrous auto-immune thyroiditis in children: clinical, laboratory and TSH-receptor antibody studies. Eur J Pediatr 149: 529-533.
24. Young LA (1979) Dysthyroid ophthalmopathy in children. J Pediatr Ophthalmol Strab 16: 105-107.
25. Uretsky SH, Kennerdell JS, Gutai JP (1980) Graves' ophthalmopathy in childhood and adolescence. Arch Ophthalmol 98: 1963-1964.
26. Glaser NS, Styne DM (1997) Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 82: 1719-1726.
27. Antoniazzi F, Zamboni G, Cerini R, Lauriola S, Dall'Agnola A, Tato L (2004) Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence. J Pediatr 144: 527-531.
28. Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K (2000) Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid 10: 809-813.
29. Nishikawa M, Yoshimura M, Toyoda N, Masaki H, Yonemoto T, Gondou A, Kato T, Kurokawa H, Furumura T, Inada M (1993) Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy. Acta Endocrinol (Copenh) 129: 213-219.
30. Mussa GC, Corrias A, Silvestro L, Battan E, Mostert M, Mussa F, Pellegrino D (1999) Factors at onset predictive of lasting remission in pediatric patients with Graves' disease followed for at least three years. J Pediatr Endocrinol Metab 12: 537-541.
31. Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW (1997) Autoimmune hyperthyroidism in prepubertal children and adolescents: Comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 7: 755-760.
32. Yamashita Y, Yamane K, Tamura T, Okubo M, Kohno N (2004) Onset age is associated with outcome of radioiodine therapy in Graves' disease. Endocr J 51: 127-132.
33. Vitti P, Rago T, Chiovato L, Pallini S, Santini F, Fiore E, Rocchi R, Martino E, Pinchera A (1997) Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 7: 369-375.